🔎 Trials Near Me

Avaleht › Eesnäärmevähk › Michigan

Eesnäärmevähk kliinilised uuringud osariigis Michigan

56 uuringut haiguse Eesnäärmevähk jaoks otsivad osalejaid osariigis Michigan.

Linnad osariigis Michigan

Ametlik uuringutekst (inglise keeles)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
  • ja veel 8
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 2. okt 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Bronson Battle Creek, Battle Creek
  • Henry Ford Cancer Institute-Downriver, Brownstown
  • ja veel 17
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 2. okt 2026 · NCT07200830

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MyMichigan Medical Center Gratiot, Alma
  • MyMichigan Medical Center Alpena, Alpena
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • ja veel 68
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
  • ja veel 3
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • Trinity Health Medical Center - Brighton, Brighton
  • ja veel 32
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT03866382

Precision-Based Genomics in Prostate Cancer

  • University of Michigan, Ann Arbor
VärbamineVaatlusuuring
Vanused 18–120 · Mehed · Uuendatud 28. sept 2026 · NCT04706663

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

  • Research Site, Ann Arbor
  • Research Site, Detroit
VärbamineFaas 1/2
Vanused 18–130 · Mehed · Uuendatud 25. sept 2026 · NCT07181161

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
VärbamineFaas 1/2
Vanused 18 ja vanemad · Mehed · Uuendatud 25. sept 2026 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Henry Ford Hospital ( Site 0015), Detroit
  • Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT06136650

A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

  • Start Midwest, Grand Rapids
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 25. sept 2026 · NCT07746713

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • START Midwest, Grand Rapids
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 24. sept 2026 · NCT07719361

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Barbara Ann Karmanos Cancer Institute, Detroit
  • BAMF Health Inc., Grand Rapids
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07114601

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • Barbara Ann Karmanos Cancer Institute, Lansing
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 22. sept 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Karmanos Cancer Institute, Detroit
VärbamineFaas 3
Vanused 18–100 · Mehed · Uuendatud 22. sept 2026 · NCT06855277

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

  • BAMF Health, Grand Rapids
VärbamineFaas 2/3
Vanused 18 ja vanemad · Mehed · Uuendatud 21. sept 2026 · NCT07831824

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 17. sept 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • University of Michigan ( Site 0005), Ann Arbor
  • Henry Ford Hospital ( Site 0035), Detroit
  • Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 17. sept 2026 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

  • GSK Investigational Site, Grand Rapids
VärbamineFaas 1/2
Vanused 18 ja vanemad · Mehed · Uuendatud 16. sept 2026 · NCT07332455

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • BAMF Health, Grand Rapids
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 15. sept 2026 · NCT07581184

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Wayne State University, Detroit
Värbamine
Vanused 18 ja vanemad · Mehed · Uuendatud 14. sept 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • BAMF Health, Grand Rapids
  • Corewell Health, Grand Rapids
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 11. sept 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Trinity Health Medical Center - Brighton, Brighton
  • ja veel 21
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 10. sept 2026 · NCT05946213

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

  • Research Site, Grand Rapids
VärbamineFaas 1/2
Vanused 18 ja vanemad · Mehed · Uuendatud 2. sept 2026 · NCT07192614

Prostate Active Surveillance Study

  • University of Michigan, Ann Arbor
VärbamineVaatlusuuring
Vanused 21 ja vanemad · Mehed · Uuendatud 2. sept 2026 · NCT00756665

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Henry Ford Cancer Institute-Downriver, Brownstown
  • Henry Ford Health Center - Brownstown, Brownstown
  • Henry Ford Health Center - Chesterfield, Chesterfield
  • ja veel 13
VärbamineTerved vabatahtlikud oodatud
Vanused 45–75 · Kõik sood · Uuendatud 2. sept 2026 · NCT06995898

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

  • Rogel Cancer Center, Ann Arbor
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Mehed · Uuendatud 27. aug 2026 · NCT07050433

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Grand Rapids
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 26. aug 2026 · NCT07611110

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Henry Ford, Novi
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 24. aug 2026 · NCT07745361

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • Karmanos Cancer Institute, Detroit
VärbamineFaas 1/2
Vanused 18 ja vanemad · Mehed · Uuendatud 20. aug 2026 · NCT06785636

EDRN Prostate MRI Biomarker Study

  • University of Michigan, Ann Arbor
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Mehed · Uuendatud 17. aug 2026 · NCT03784924

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

  • University of Michigan Health, Ann Arbor
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 14. aug 2026 · NCT04812366

SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Mehed · Uuendatud 27. juuli 2026 · NCT07096999

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • McLaren Cancer Institute-Bay City, Bay City
  • ja veel 19
VärbamineFaas 3
Vanused 18 ja vanemad · Mehed · Uuendatud 14. juuli 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Karmanos, Detroit
VärbamineFaas 1
Vanused 18 ja vanemad · Mehed · Uuendatud 9. juuli 2026 · NCT05413421

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

  • Karmanos Cancer Institute, Detroit
Värbamine
Vanused 20–79 · Kõik sood · Uuendatud 23. juuni 2026 · NCT07436078

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • McLaren Proton Therapy Center, Flint
Värbamine
Vanused 18 ja vanemad · Mehed · Uuendatud 17. juuni 2026 · NCT00969111

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

  • VA Ann Arbor Healthcare System, Ann Arbor
VärbamineFaas 2
Vanused 18 ja vanemad · Mehed · Uuendatud 15. juuni 2026 · NCT05422911

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer

  • University of Michigan Rogel Cancer Center, Ann Arbor
VärbamineVaatlusuuring
Vanused 35–70 · Mehed · Uuendatud 12. juuni 2026 · NCT07645391

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.